# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Medifast (NYSE:MED) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $(0.22) by 200 ...
Medifast (NYSE:MED) Q3 expected to be more than $(0.60) vs $(0.30) Est. sees Q3 sales of $70.000 million-$90.000 million vs $9...
Medifast (NYSE:MED) Q2 expected to be more than $(0.55) vs $(0.08) Est. sees Q2 sales of $85.000 million-$105.000 million vs $...
Medifast (NYSE:MED) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.27) by 74.0...